SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
15963079
Source:
http://linkedlifedata.com/resource/pubmed/id/15963079
Search
Subject
(
58
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0087111
,
umls-concept:C0205174
,
umls-concept:C0231175
,
umls-concept:C0750729
pubmed:issue
1
pubmed:dateCreated
2005-6-20
pubmed:abstractText
A standard third-line treatment is lacking, and European guidelines recommend performing culture in these patients. However, the use of this procedure as 'routine practice' is definitively not feasible.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8707234
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Amoxicillin
,
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Metronidazole
,
http://linkedlifedata.com/resource/pubmed/chemical/Ofloxacin
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0269-2813
pubmed:author
pubmed-author:BernabucciVV
,
pubmed-author:CavinaMM
,
pubmed-author:De FrancescoVV
,
pubmed-author:GattaLL
,
pubmed-author:HassanCC
,
pubmed-author:IerardiEE
,
pubmed-author:MoriniSS
,
pubmed-author:PernaFF
,
pubmed-author:RicciCC
,
pubmed-author:TampieriAA
,
pubmed-author:VairaDD
,
pubmed-author:ZulloAA
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
22
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
45-9
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:15963079-Amoxicillin
,
pubmed-meshheading:15963079-Anti-Bacterial Agents
,
pubmed-meshheading:15963079-Drug Evaluation
,
pubmed-meshheading:15963079-Drug Resistance, Bacterial
,
pubmed-meshheading:15963079-Drug Therapy, Combination
,
pubmed-meshheading:15963079-Female
,
pubmed-meshheading:15963079-Follow-Up Studies
,
pubmed-meshheading:15963079-Helicobacter Infections
,
pubmed-meshheading:15963079-Helicobacter pylori
,
pubmed-meshheading:15963079-Humans
,
pubmed-meshheading:15963079-Male
,
pubmed-meshheading:15963079-Metronidazole
,
pubmed-meshheading:15963079-Middle Aged
,
pubmed-meshheading:15963079-Ofloxacin
,
pubmed-meshheading:15963079-Prospective Studies
,
pubmed-meshheading:15963079-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.
pubmed:affiliation
Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy.
pubmed:publicationType
Journal Article